90 filings
Page 2 of 5
8-K
v7e2do4
10 Mar 22
Codiak BioSciences Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Operational Progress
4:07pm
8-K
nbmvir309zk zurp
30 Nov 21
Patient Dosing Expected 1H 2022
8:36am
8-K
xc9mw01s
17 Nov 21
Regulation FD Disclosure
7:00am
8-K
8589ym 9vn8bki63mfj
16 Nov 21
Entry into a Material Definitive Agreement
6:58am
EFFECT
0hjj08aa
16 Nov 21
Notice of effectiveness
12:15am
UPLOAD
5cpbk2
12 Nov 21
Letter from SEC
12:00am
CORRESP
eh427 r6tvn4
12 Nov 21
Correspondence with SEC
12:00am
8-K
loy3y
4 Nov 21
Entry into a Material Definitive Agreement
5:27pm
S-3
2v87i5gjhb kd4g5x
4 Nov 21
Shelf registration
5:04pm
8-K
aelwne8c6mwcx
4 Nov 21
Codiak BioSciences Reports Third Quarter 2021 Financial Results and Recent Operational Progress
4:07pm
8-K
k9ukrwlp1
2 Nov 21
Lonza to Acquire Codiak BioSciences Exosomes Manufacturing Facility and Establish a Long-Term Strategic Collaboration
8:08am
8-K
cb95 9fnp2wu6
7 Oct 21
Termination of a Material Definitive Agreement
4:16pm
8-K
d80b04ryhj
21 Sep 21
Entry into a Material Definitive Agreement
4:01pm
8-K
vtdaofzc3i48g9f
18 Aug 21
Departure of Directors or Certain Officers
4:06pm
8-K
sc4kdzv z9banjp6e
5 Aug 21
Codiak BioSciences Reports Second Quarter 2021 Financial Results and Operational Progress
4:08pm
8-K
bwml9nqalq
6 Jul 21
Departure of Directors or Certain Officers
5:01pm
8-K
qf014dlqhd2f
23 Jun 21
Submission of Matters to a Vote of Security Holders
4:05pm